Search results for

Austria A L 1 (2) Dr Thomas M Haffner Vienna ? 2 (3) Patnentwalte Kliment Vienna ? 3 (1) Sonn Pawloy Weinzinger & Wolfram Vienna ? 4 (-) DI Berger Vienna ? 5 (4) Kopecky & Schwarz Vienna ?

Africa

As investment into Latin America increases, protecting famous trade marks becomes more important. Tony Ferguson compares the protection available in Argentina, Uruguay, Paraguay, Brazil and Chile

Interferences are a relatively rare, but nonetheless integral, part of United States patent practice. For many years, patent applicants or patentees who performed their relevant research and development work outside the United States were limited to claiming the dates of their relevant patent applications filed under the Paris Convention, the benefit of which could be claimed pursuant to 35 USC § 119 as the date of conception and reduction to practice of an invention covered in a US patent application or patent held to "interfere" with another US application or patent. Given that such persons may now seek to prove prefiling dates of conception of an invention, or of actual reduction to practice thereof, when the pertinent work was done outside the United States, it has become important for counsellors and in-house advisers of non-US based entities to pay greater attention to interference law, especially as it relates to conception and actual reduction to practice, than they did when their prospective participation in an interference proceeding was hobbled, as noted above.

In an earlier issue of this magazine, we reported on the granting of Supplementary Protection Certificates, SPCs (June 1999, Issue 90, pages 49-50).

Pre-launch patent searches can be costly and time-consuming. Andrew Inglis and Michael Molineaux examine whether they are really necessary in the UK, and compare the situation with other jurisdictions

For two decades, Canada has lagged behind its major trading partners in patenting higher life forms. Steve Garland and Kathy Lipic explain how this situation has changed, following a landmark Federal Court decision

The Colombian Patent Office denied to grant a patent on an application filed by Pfizer Inc directed to a product known as "Viagra" , whose chemical name is pyrazolepyrimidone. The reason for this decision was that the application was trying to protect a new use of a known product. About the same time, the Peruvian Patent Office granted a patent to a corresponding patent application for the same subject matter.

The signing of the US-Vietnam trade agreement on July 13 has been met with more than a little scepticism by industry observers and local IP practitioners.

On Sunday July 16, in Yokahama, Japan, the most significant event since the creation of the internet domain name system was played out. As a finale, the main protagonist, the International Corporation for Assigned Names and Numbers, agreed to extend the number of top-level domain names (TLDs).